AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.

The raises in operating costs and expenses in ’09 2009 over the comparable 2008 periods were due to increased primarily selling, general and administrative expenses from the commercialization of Feraheme. THE BUSINESS reported a net lack of $18.4 million, or a lack of $1.07 per basic and diluted share, december 31 for the quarter ended, 2009, as in comparison to a net lack of $21.8 million, or a lack of $1.28 per basic and diluted talk about, for the same period in 2008. Net loss for the year ended December 31, 2009 was $93.4 million, or a loss of $5.46 per basic and diluted share, when compared with a net lack of $71.6 million, or a loss of $4.22 per diluted and basic share for the same period in 2008.When will the world open up its eye collectively to the damage it inflicts on itself? How happy and how real of lives can we actually live? Why don’t we strive to be all that people can be? Study displays how polluting of the environment creates developmental complications in infantsA Columbia University study that partnered with Chongqing Medical University linked toxic air pollution to developmental problems in infants from the womb. The universities studied medical effects that polluting of the environment cast onto moms and children living near an inefficient coal-fired power plant in China in 2002.